About Rapidx Pathology Labs
Rapidx Pathology Labs is a Healthcare company based in Viluppuram (India) founded in 2019, and was acquired by Orange health in August 2022. Diagnostic pathology services are provided by a standalone laboratory. Its Indian entity Cauro Diagnostics Private Limited reported revenue of ₹9.70 Cr. Its focus areas include Clinical Laboratories.
Company details
Rapidx Pathology Labs was established in 2019 in Viluppuram, India, as a standalone facility in the healthcare diagnostics sector. Core operations involve pathology testing for medical diagnostics, including sample analysis and reporting. Services are delivered to support local healthcare needs, with a focus on routine and specialized tests. The lab functions independently, serving the regional community in southern India.
- Headquarters Viluppuram, India
- Stage Acquired
- SectorsHealthcare
- Website rapidx.co.in
- Social LinkedIn
- Acquired by Orange health (Aug 2022)
- Legal Name Cauro Diagnostics Private Limited
- Date of Incorporation 01 Oct, 2018
- Jurisdiction Gurgaon, Haryana, India
- Annual Revenue₹9.70 Cr
FY 2021 · +613% YoY
- Net Profit₹39.9 Lakh
FY 2021 · 4% margin
- EBITDA₹60.6 Lakh
FY 2021 · 6% margin
- Investors
- Acquired byOrange health
(Aug 2022)
Associated legal entities of Rapidx Pathology Labs
Rapidx Pathology Labs operates through Cauro Diagnostics Private Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cauro Diagnostics Private Limited CIN U74999HR2018PTC076183 | Amalgamated | 01 Oct 2018 | Gurgaon, Haryana | ₹9.7 Cr | 73 | 2 | View details |
Investors in Rapidx Pathology Labs
Rapidx Pathology Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Orange health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
At-home diagnostic tests are booked and collected by phlebotomists. | 2020 | orangehealth.in | Bengaluru, India |
Investor details for Rapidx Pathology Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cauro Diagnostics Private Limited (Rapidx Pathology Labs)
Cauro Diagnostics Private Limited is the primary company behind Rapidx Pathology Labs. The board of Cauro Diagnostics Private Limited currently have 2 directors; the longest-serving is Tarun Bhambra, appointed in 2021. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tarun Bhambra DIN 08664651 | Additional Director | 08 Dec 2021 | 4 yrs 10 mo | Cauro Diagnostics Private Limited |
| Dhruv Gupta DIN 03397438 | Additional Director | 08 Dec 2021 | 4 yrs 10 mo | Cauro Diagnostics Private Limited |
Financials of Rapidx Pathology Labs
Figures of Cauro Diagnostics Private Limited, the primary company behind Rapidx Pathology Labs, for FY 2021. Revenue was ₹9.70 Cr (+613% year on year). Net profit was ₹39.9 Lakh (4% margin). EBITDA was ₹60.6 Lakh (6% margin).
- ₹9.70 CrRevenue · FY 2021 · +613% YoY
- ₹39.9 LakhNet profit · 4% margin
- ₹60.6 LakhEBITDA · 6% margin
- ₹9.7 LakhPaid-up capital
- 73Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Cauro Diagnostics Private Limited are on its company page.
Detailed financial statements for Rapidx Pathology Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Rapidx Pathology Labs
2 dated milestones of Rapidx Pathology Labs across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Rapidx Pathology Labs is founded.
- Exit Acquired by Orange health.
Top companies in Diagnostics Laboratories
3 companies that operate in the same segment as Rapidx Pathology Labs (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Diagnostic testing centers for pathology and health screenings are operated. | 1996 | Mumbai, Maharashtra, India | USD 63.59 M | USD 88.36 M | 1,950 | |
Chain of pathology and radiology labs | 1949 | Gurugram, Haryana, India | USD 13.9 M | USD 294.49 M | 5,310 | |
Home-based diagnostic tests are booked via an online platform. | 2018 | Noida, Uttar Pradesh, India | USD 116.42 M | USD 41.86 M | 2,308 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rapidx Pathology Labs
Rapidx Pathology Labs was founded in 2019.
Rapidx Pathology Labs is headquartered in Viluppuram, India. It is registered at Viluppuram, Tamil Nadu, India.
The primary company behind Rapidx Pathology Labs, Cauro Diagnostics Private Limited, reported revenue of ₹9.70 Cr for FY 2021, up 613% year on year.
Rapidx Pathology Labs was established in 2019 in Viluppuram, India, as a standalone facility in the healthcare diagnostics sector. Core operations involve pathology testing for medical diagnostics, including sample analysis and reporting. Services are delivered to support local healthcare needs, with a focus on routine and specialized tests. The lab functions independently, serving the regional community in southern India.
Rapidx Pathology Labs has 1 investor. Key investors include Orange health.
Rapidx Pathology Labs operates through Cauro Diagnostics Private Limited.
Yes. Rapidx Pathology Labs was acquired by Orange health in August 2022.
The legal entities of Rapidx Pathology Labs currently have 2 directors, including Tarun Bhambra, Dhruv Gupta.